Vaidyanathan, G., Mease, R., Affleck, D., Chen, Y., Welsh, P., Hens, M., … Zalutsky, M. (2009). An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma. In JOURNAL OF NUCLEAR MEDICINE (Vol. 50). SOC NUCLEAR MEDICINE INC.

Vaidyanathan, Ganesan, Ronnie Mease, Donna Affleck, Ying Chen, Philip Welsh, Marc Hens, Martin Pomper, and Michael Zalutsky. “An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma.” In JOURNAL OF NUCLEAR MEDICINE, Vol. 50. SOC NUCLEAR MEDICINE INC, 2009.

Vaidyanathan G, Mease R, Affleck D, Chen Y, Welsh P, Hens M, et al. An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma. In: JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 2009.

Vaidyanathan, Ganesan, et al. “An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma.” JOURNAL OF NUCLEAR MEDICINE, vol. 50, SOC NUCLEAR MEDICINE INC, 2009.

Vaidyanathan G, Mease R, Affleck D, Chen Y, Welsh P, Hens M, Pomper M, Zalutsky M. An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC; 2009.